Pfizer Inc. (PFE) Financials Nov 18, 2014, 7:25 p.
Post# of 250602
Posted On: 11/18/2014 11:10:13 PM
Pfizer Inc. (PFE) Financials Nov 18, 2014, 7:25 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Pfizer Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 50.01B 67.06B 65.26B 58.99B 51.58B
Cost of Goods Sold (COGS) incl. D&A 11.59B 20.71B 18.82B 16.21B 13.95B
COGS excluding D&A 6.83B 12.23B 9.91B 8.6B 7.54B
Depreciation & Amortization Expense 4.76B 8.49B 8.91B 7.61B 6.41B
Depreciation 1.76B 3.08B 3.11B 2.21B 1.61B
Amortization of Intangibles 3B 5.4B 5.8B 5.4B 4.8B
Gross Income 38.42B 46.34B 46.44B 42.78B 37.63B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 22.41B 28.61B 27.13B 23.81B 20.74B
Research & Development 7.75B 9.36B 8.4B 7.34B 6.55B
Other SG&A 14.66B 19.25B 18.73B 16.47B 14.19B
Other Operating Expense 0 0 0 0 0
Unusual Expense 5.96B 8.03B 6.36B 6.19B 1.26B
EBIT after Unusual Expense (5.96B) (8.03B) (6.36B) (6.19B) (1.26B)
Non Operating Income/Expense 787M 971M 577M 447M 642M
Non-Operating Interest Income 746M 402M 456M 383M 403M
Equity in Affiliates (Pretax) 482M 0 - - 459M
Interest Expense 1.23B 1.8B 1.68B 1.52B 1.41B
Gross Interest Expense 1.27B 1.83B 1.73B 1.57B 1.45B
Interest Capitalized 34M 36M 50M 41M 32M
Pretax Income 10.83B 9.28B 12.3B 12.08B 15.72B
Income Tax 2.2B 1.07B 3.91B 2.56B 4.31B
Income Tax - Current Domestic 10.24B (3.08B) 1.56B (796M) 36M
Income Tax - Current Foreign 1.54B 2.21B 2.05B 2.62B 2.54B
Income Tax - Deferred Domestic (10.1B) 2B 124M 523M 2.09B
Income Tax - Deferred Foreign 513M (67M) 183M 216M (365M)
Income Tax Credits 0 0 - - 0
Equity in Affiliates 0 0 - - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 8.63B 8.21B 8.4B 9.52B 11.41B
Minority Interest Expense 9M 31M 40M 28M 30M
Net Income 8.62B 8.18B 8.36B 9.49B 11.38B
Extraordinaries & Discontinued Operations 14M 77M 1.65B 5.08B 10.62B
Extra Items & Gain/Loss Sale Of Assets 0 (11M) 1.3B 4.78B 10.35B
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 14M 88M 350M 297M 269M
Net Income After Extraordinaries 8.64B 8.26B 10.01B 14.57B 22B
Preferred Dividends 2M 2M 2M 2M 2M
Net Income Available to Common 8.62B 8.18B 8.35B 9.49B 11.38B
EPS (Basic) 1.23 1.03 1.11 1.31 1.71
Basic Shares Outstanding 7.01B 8.04B 7.82B 7.44B 6.81B
EPS (Diluted) 1.23 1.02 1.11 1.30 1.69
Diluted Shares Outstanding 7.05B 8.07B 7.87B 7.51B 6.9B
EBITDA 20.77B 26.22B 28.22B 26.58B 23.3B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Pfizer Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 50.01B 67.06B 65.26B 58.99B 51.58B
Cost of Goods Sold (COGS) incl. D&A 11.59B 20.71B 18.82B 16.21B 13.95B
COGS excluding D&A 6.83B 12.23B 9.91B 8.6B 7.54B
Depreciation & Amortization Expense 4.76B 8.49B 8.91B 7.61B 6.41B
Depreciation 1.76B 3.08B 3.11B 2.21B 1.61B
Amortization of Intangibles 3B 5.4B 5.8B 5.4B 4.8B
Gross Income 38.42B 46.34B 46.44B 42.78B 37.63B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 22.41B 28.61B 27.13B 23.81B 20.74B
Research & Development 7.75B 9.36B 8.4B 7.34B 6.55B
Other SG&A 14.66B 19.25B 18.73B 16.47B 14.19B
Other Operating Expense 0 0 0 0 0
Unusual Expense 5.96B 8.03B 6.36B 6.19B 1.26B
EBIT after Unusual Expense (5.96B) (8.03B) (6.36B) (6.19B) (1.26B)
Non Operating Income/Expense 787M 971M 577M 447M 642M
Non-Operating Interest Income 746M 402M 456M 383M 403M
Equity in Affiliates (Pretax) 482M 0 - - 459M
Interest Expense 1.23B 1.8B 1.68B 1.52B 1.41B
Gross Interest Expense 1.27B 1.83B 1.73B 1.57B 1.45B
Interest Capitalized 34M 36M 50M 41M 32M
Pretax Income 10.83B 9.28B 12.3B 12.08B 15.72B
Income Tax 2.2B 1.07B 3.91B 2.56B 4.31B
Income Tax - Current Domestic 10.24B (3.08B) 1.56B (796M) 36M
Income Tax - Current Foreign 1.54B 2.21B 2.05B 2.62B 2.54B
Income Tax - Deferred Domestic (10.1B) 2B 124M 523M 2.09B
Income Tax - Deferred Foreign 513M (67M) 183M 216M (365M)
Income Tax Credits 0 0 - - 0
Equity in Affiliates 0 0 - - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 8.63B 8.21B 8.4B 9.52B 11.41B
Minority Interest Expense 9M 31M 40M 28M 30M
Net Income 8.62B 8.18B 8.36B 9.49B 11.38B
Extraordinaries & Discontinued Operations 14M 77M 1.65B 5.08B 10.62B
Extra Items & Gain/Loss Sale Of Assets 0 (11M) 1.3B 4.78B 10.35B
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 14M 88M 350M 297M 269M
Net Income After Extraordinaries 8.64B 8.26B 10.01B 14.57B 22B
Preferred Dividends 2M 2M 2M 2M 2M
Net Income Available to Common 8.62B 8.18B 8.35B 9.49B 11.38B
EPS (Basic) 1.23 1.03 1.11 1.31 1.71
Basic Shares Outstanding 7.01B 8.04B 7.82B 7.44B 6.81B
EPS (Diluted) 1.23 1.02 1.11 1.30 1.69
Diluted Shares Outstanding 7.05B 8.07B 7.87B 7.51B 6.9B
EBITDA 20.77B 26.22B 28.22B 26.58B 23.3B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼